<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127320">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01444729</url>
  </required_header>
  <id_info>
    <org_study_id>B1531005</org_study_id>
    <nct_id>NCT01444729</nct_id>
  </id_info>
  <brief_title>Post Approval Commitment Study</brief_title>
  <official_title>A Non-Interventional Post Approval Commitment Study To Evaluate The Outcomes Of The Various Treatment Options For Dupuytren's Contracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Endo Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endo Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An agreement has been made to conduct a post-approval commitment study that provides
      supplementary information relating to the use of XiapexÂ® as well as other
      non-pharmacological treatments for Dupuytren's contracture by health care professionals in a
      real world clinical setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      phase 4, open label, multi-center, prospective non-interventional descriptive
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clinical treatment success as assessed by goniometry</measure>
    <time_frame>an expected average of 5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>treatment satisfaction using the Patient or Physician Global Assessment and Satisfaction questionnaires</measure>
    <time_frame>an expected average of 5 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment option as determined by treating physician in consultation with patient</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Dupuytren's Contracture</condition>
  <arm_group>
    <arm_group_label>xiapex</arm_group_label>
    <description>Subject treated with Xiapex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <description>Fasciotomy or fasciectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xiapex</intervention_name>
    <description>Xiapex administration will follow SMPC</description>
    <arm_group_label>xiapex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgery</intervention_name>
    <description>Non-pharmacological treatment</description>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - Adults with a palpable cord eligible for the treatment of Dupuytren's contracture
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with a palpable cord eligible for the treatment of Dupuytren's contracture

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veronica Urdaneta</last_name>
    <role>Study Director</role>
    <affiliation>Endo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Auxilium Investigational Site</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auxilium Investigational Site</name>
      <address>
        <city>Drammen</city>
        <zip>3004</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auxilium Investigational Site</name>
      <address>
        <city>Malaga</city>
        <state>Andalucia</state>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auxilium Investigational Site</name>
      <address>
        <city>Alcorcon</city>
        <state>Madrid</state>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auxilium Investigational Site</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auxilium Investigational Site</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auxilium Investigational Site</name>
      <address>
        <city>Valladolid</city>
        <zip>46011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
    <country>Spain</country>
  </location_countries>
  <removed_countries>
    <country>United Kingdom</country>
  </removed_countries>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 17, 2016</lastchanged_date>
  <firstreceived_date>September 8, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>'Dupuytren's contracture'</keyword>
  <keyword>'xiapex'</keyword>
  <keyword>'surgery'</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
